INVIVO THERAPEUTICS HLDGS CO's ticker is and the CUSIP is 46186M605. A total of 15 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tower Research Capital LLC (TRC) | 7,593 | $8,504 | 0.00% |
| Milestone Investment Advisors LLC | 1 | $2 | 0.00% |
| Renaissance Technologies | 13,921 | $16 | 0.00% |
| Allworth Financial LP | 1 | $2 | 0.00% |
| VANGUARD GROUP INC | 28,938 | $32,411 | 0.00% |
| Colonial Trust Advisors | 2 | $2 | 0.00% |
| UBS Group AG | 102 | $114 | 0.00% |
| Sugarloaf Wealth Management, LLC | 1 | $1 | 0.00% |
| OSAIC HOLDINGS, INC. | 6 | $6 | 0.00% |
| WELLS FARGO & COMPANY/MN | 23 | $26 | 0.00% |